Standardization of arterial stiffness measurements make them ready for use in clinical practice by Van Bortel, Luc M et al.
American Journal of Hypertension 1
COMMENTARY
Standardization of Arterial Stiffness Measurements Make 
Them Ready for Use in Clinical Practice
Luc M. Van Bortel,1 Tine De Backer,2 and Patrick Segers3 
CAROTID-FEMORAL PULSE WAVE VELOCITY IS THE GOLD 
STANDARD FOR NONINVASIVE MEASUREMENT OF 
ARTERIAL STIFFNESS
Arterial stiffness can be measured as regional stiffness 
expressed as pulse wave velocity (PWV), local stiffness 
expressed as distensibility coefficient or PWV, and systemic 
stiffness. Many devices are commercially available to meas-
ure arterial stiffness of different vascular territories. However, 
not all vascular territories have shown predictive value for 
cardiovascular events.1,2 Predictive value has been shown for 
the local stiffness of the carotid artery (CA) and the femo-
ral artery (FA).2,3 Arterial segments with predictive value 
are the carotid-femoral, brachial-ankle, cardio-ankle, and 
the aortic arch segments.2 Carotid–femoral PWV (cfPWV) 
also has “incremental” value, above and beyond classical 
risk scores. It can reclassify patients into higher and lower 
risk categories.1 Therefore, arterial stiffness should be deter-
mined noninvasively by the measurement of cfPWV. This has 
been recommended by the 2010 guideline for assessment of 
cardiovascular risk in asymptomatic adults of the American 
College of Cardiology Foundation and the American Heart 
Association (AHA), the 2013 guidelines for the management 
of arterial hypertension of the European Society of Cardiology 
and the European Society of Hypertension (ESH), and the 
2015 AHA recommendations for improving and standard-
izing vascular research on arterial stiffness.1,4
THE METHOD TO MEASURE cfPWV SHOULD BE 
STANDARDIZED
To calculate PWV, the path length traveled by the pulse 
wave and the transit time have to be measured. A large major-
ity of devices adequately measure transit time, but many dif-
ferent ways have been proposed as best noninvasive estimate 
of the path length traveled by the pulse. The most frequently 
used distance estimates are shown in Table 1. Using magnetic 
resonance imaging, the traveled path length for cfPWV was 
measured as the arterial length from the ascending aorta to 
the measurement point at the FA minus the length from the 
ascending aorta to the measurement point at the CA.5 In that 
study with adult Europeans, 80% of the full carotid–femoral 
(CA-FA) distance appeared the best estimate. The full CA-FA 
distance overestimates the traveled path length and cfPWV 
by 25%, while the subtracted distance using the suprasternal 
notch (SSN; SSN-to-FA minus SSN-to-CA) underestimates 
the traveled path length by about 10%. This lack of stand-
ardization makes it impossible to compare cfPWV data 
from studies using different distance definitions, to compare 
cfPWV data with stiffness at other vascular territories, to 
correctly interpret data in clinical practice or to use a single 
cutoff value. Indeed, a cutoff value of 10 m/s using the 80% 
CA-FA distance method is equivalent to 12.5 m/s when using 
the full CA-FA distance as advised in the Complior manual 
and is equivalent to 8.94 m/s when using the SSN-subtracted 
distance as advised in the Sphygmocor manual.
In the present issue of this Journal, Sugawara et al.6 pre-
sent the results of a similar magnetic resonance imaging 
study and found the 80% CA-FA distance also being the best 
estimate of the effective path length in Japanese adults. In 
addition, a similar underestimation of 9% was found for the 
SSN-subtracted distance. After applying a conversion fac-
tor of 1.1, the SSN-subtracted distance correlated very well 
with the 80% CA-FA distance. The study by Sugawara et al. 
supports the consensus document of the Artery Society, the 
ESH Working Group on Vascular Structure and Function 
and the European Network for Noninvasive Investigation of 
Large Arteries to promote 80% of the full CA-FA distance as 
the standard method for cfPWV measurement.7
The 2015 AHA recommendations for vascular research 
on arterial stiffness also recommend the use of the 80% 
CA-FA distance, but at the same time also promote the 
use of the SSN-subtracted distance. Authors find this rec-
ommendation quite strange, as by recommending 2 dif-
ferent methods, standardization is lost. It was argued that 
cfPWV using the SSN-subtracted distance correlates very 
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well with true aortic PWV (from aortic valve to aortic 
bifurcation) measured invasively.4 However, the pathway 
of cfPWV substantially differs from the true aortic path-
way: cfPWV also contains the more muscular (stiffer) iliac 
arteries and lacks the highly distensible (less stiff) ascend-
ing aorta and part of the aortic arch up to the branching 
off of the brachiocephalic artery. This also explains why 
true aortic PWV is lower than cfPWV. Although it might 
be hypothesized that true aortic PWV may have better 
predictive value than cfPWV, these epidemiologic data are 
lacking. In addition, true aortic stiffness can only be meas-
ured invasively and is therefore not suitable for use in daily 
clinical practice. Because of these arguments and because 
SSN-subtracted distance requires 2 distance measurements 
which can increase the error of the measurement, it is the 
authors’ position that the SSN-subtracted distance should 
not be recommended as alternative distance method for 
cfPWV assessment.
A possible source of error in the calculation of cfPWV 
arises from the fact that from the branching off of the 
brachiocephalic artery, the pulse wave travels in opposite 
directions: up to the measurement point at the CA and 
down to the measurement point at the FA. Upon arrival 
of the pulse wave at the CA, it also traveled further down 
in the descending aorta. By subtracting these 2 pathways, 
both the studies by Huybrechts et al.5 and Sugawara et al.6 
assume an identical PWV in the brachiocephalic-to-CA 
and aortic arch-to-descending thoracic aorta segments, 
which may not be the case as discussed earlier.8 The poten-
tial error can be estimated using published data: assum-
ing (i) an average length of the brachiocephalic-to-CA 
of 11.7 cm;5 (ii) that PWV in the brachiocephalic-to-CA 
segment equals CA PWV (6.50 m/s in normotensives, 7.48 
m/s in hypertensives);9 and (iii) PWV in the aortic-arch-
to-descending-aorta segment equals PWV of the aortic 
arch close to the branching off of the brachiocephalic 
artery (4.88 m/s and 6.70 m/s, respectively).10 When 
using the 80% CA-FA distance to calculate cfPWV, these 
assumptions lead to an underestimation of cfPWV of 5.0% 
in normotensives, and of 1.4% in hypertensives. With 
the same assumptions, use of the SSN-subtracted dis-
tance would underestimate cfPWV by 15.1% and 11.9%, 
respectively. The error, however, is likely to be much less as 
arterial stiffness presumably increases gradually, with the 
average stiffness of the brachiocephalic-to-CA being lower 
than CA stiffness and the aortic-arch-to-descending-aorta 
stiffness being higher than the stiffness of the aortic arch 
near the brachiocephalic branching.
Measurements in the magnetic resonance imaging study 
by Huybrechts et  al. were done at the right body side. 
Bossuyt et  al. found the traveled path length in the same 
subjects at the left side 1 cm shorter than at the right body 
side.11 The consensus document advised to perform meas-
urements preferentially at the right body side.7 Alternatively, 
the standard distance at the left side can be reduced by 1 cm. 
This small left–right difference of about 2%, which might not 
be clinically relevant, has also been found in another study in 
Europeans.12 However, Sugawara did not find any left–right 
difference in the Japanese population.13
Finally, to avoid much larger inaccuracies than those 
mentioned above, it should be underlined that recom-
mendations for user procedures as described earlier 
in guidelines like the consensus document7 should be 
followed.
Table 1. Comparison of MRI measured path length with different tape measure distances
Distance mean 
(SD) (cm)
Tape measure minus  
reference distance (cm)a
Tape measure deviation  
from reference distance (%)b
(AA-FA)-(AA-CA) 50.7 (4.2)
Reference distancec
(CA-FA)-(SN-CA) 48.3 (4.1) −2.35 (3.8) −4.73
(CA-FA)-(SSN-CA) 53.0 (4.1) 2.32 (3.8) +4.54
(SN-FA)-(SN-CA) 35.9 (4.3) −14.77 (3.9) −29.19
(SSN-FA)-(SSN-CA) 45.5 (4.5) −5.11 (3.5) −10.26
(SSN-UMB) + (UMB-FA) 57.7 (4.5) 7.15 (4.0) +13.81
(CA-FA) 63.6 (4.4) 12.99 (4.2) +25.44
[(SSN-UMB) + (UMB-FA)]-(SN-CA) 42.3 (4.7) −8.18 (4.1) −16.57
[(SSN-UMB) + (UMB-FA)]-(SSN-CA) 47.0 (4.7) −3.51 (4.1) −7.30
(CA-FA) × 0.8 50.9 (3.5) 0.26 (3.8) +0.39
Body height/4 + 7.28 50.2 (2.3) −0.50 (3.9) −0.99
Body height × 0.29 49.8 (2.6) −0.90 (4.0) −1.78
Abbreviations: AA, ascending aorta; CA, carotid artery; FA, femoral artery; MRI, magnetic resonance imaging; SN, sternal notch; SSN, 
suprasternal notch; UMB, umbilicus.
aTape measure: the body surface distance measured by tape measure.
bDeviation is calculated as (mean tape measure distance)/(mean reference distance) × 100.
cReference distance is the traveled path length measured by MRI.
Adapted from the studies of Huybrechts et al. and Van Bortel et al.5,7
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EIGHTY PERCENT OF THE FULL CA-FA DISTANCE SHOULD 
BE USED AS STANDARD DISTANCE TO CALCULATE 
STANDARD cfPWV IN DAILY CLINICAL PRACTICE
The available data, in Europeans and Japanese, indicate that 
the effective path length for calculation of cfPWV is best esti-
mated as 80% of the full CA-FA distance. For that standard, a 
consensus was reached for a cutoff value of 10 m/s, which rep-
resents about 4% of risk for a first major cardiovascular event 
in the next 8 years in the Framingham study.7,14 In addition, 
reference values have been published for cfPWV based on the 
80% CA-FA distance.15 These reference values show mean, 
median, and percentiles for different age and blood pressure 
categories. The availability of percentiles opens opportuni-
ties to investigate whether the trend in patient’s percentiles is 
more predictive than a general cutoff value. To interpret these 
cfPWV data or apply the cutoff value, cfPWV should first be 
converted to the standard cfPWV. This can be done using 
Table 1 or by using the calculator.
A CALCULATOR TO CONVERT ARTERIAL STIFFNESS DATA 
AND TO PROVIDE PATIENT’S PERCENTILE
To promote the use of arterial stiffness in clinical practice and 
to facilitate further research in arterial stiffness, a web-based 
calculator has been developed which can be used free of charge 
(http://bit.do/referencevalues).16 The application calculates 
cfPWV and local carotid and femoral stiffness. In addition, the 
calculated stiffness value is compared to the appropriate refer-
ence values database14,17,18 and the patient’s stiffness percentile 
is given. cfPWV is calculated for the distance used and for the 
standard distance. The calculator can also convert a measured 
cfPWV to the standard cfPWV based on the 80% CA-FA dis-
tance. For local stiffness measurements, the calculator corrects 
for the echotracking device used, the distance of the meas-
urement point proximal to the bifurcation (flow divider) and 
it converts distensibility into PWV using the Bramwell–Hill 
equation. Authors invite readers to use the calculator and to 
send suggestions for further improvement to authors.
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